Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Abbott Laboratories : DECLARES 385TH CONSECUTIVE QUARTERLY DIVIDEND

share with twitter share with LinkedIn share with facebook
share via e-mail
02/24/2020 | 09:35am EDT

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share.

This marks the 385th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2020, to shareholders of record at the close of business on April 15, 2020.

Abbott has increased its dividend payout for 48 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.

About Abbott

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.

Contact:

Tel: 224-668-0791

(C) 2020 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ABBOTT LABORATORIES
04/09ABBOTT LABORATORIES : quaterly earnings release
04/09ABBOTT : 's TriClip™ Becomes First Device of its Kind to Receive CE Mark f..
PR
04/08Grant of Extension for filing Financial Statement of Abbott Laboratories Limi..
AQ
04/07WALGREENS BOOTS ALLIANCE : to Expand Drive-Through Covid-19 Testing to 15 New Si..
DJ
04/06CVS HEALTH : Correction to CVS to Offer Drive-Through Tests at Two Stores
DJ
04/06CVS HEALTH : to Offer Drive-Through Tests at Two Stores
DJ
04/03Postponement of 71st Annual General Meeting of Abbott Laboratories Limited
AQ
03/31ABBOTT LABORATORIES : Medical Companies Win Approval for Rapid Coronavirus Tests..
DJ
03/31ABBOTT LABORATORIES : Thinking about trading options or stock in Abbott Laborato..
PR
03/30Abbott, Johnson & Johnson rise; SeaWorld, Carnival Fall
AQ
More news
Financials (USD)
Sales 2020 31 283 M
EBIT 2020 6 432 M
Net income 2020 2 738 M
Debt 2020 10 983 M
Yield 2020 1,65%
P/E ratio 2020 61,3x
P/E ratio 2021 30,3x
EV / Sales2020 5,20x
EV / Sales2021 4,48x
Capitalization 152 B
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 92,58  $
Last Close Price 86,04  $
Spread / Highest target 27,8%
Spread / Average Target 7,60%
Spread / Lowest Target -9,34%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES-2.06%151 726
MASIMO CORPORATION17.31%9 974
NOVOCURE LIMITED-16.93%6 975
ASAHI INTECC CO., LTD.2.05%6 831
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.-2.49%5 658
GETINGE5.92%5 041